Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), announces plans to add an additional 25,000 ft2 of manufacturing, in Cathedral City, California. With the recent commercialization of its fully compliant state-of-the-art extraction facility, the Company is moving forward with this expansion plan and anticipates completion of the additional manufacturing space by Q2, 2019. The facility will be full state compliant for manufacturing, packaging, distribution and transportation allowing for products to be distributed directly to state licensed dispensaries.
With this expansion, the Company has the ability to further increase its finished goods portfolio, which will include beverages, edibles, and other consumer goods. “With the Company’s recent acquisition of a new low temperature extraction methodology, we will also be able to expand our offerings to include other cannabinoids at higher concentration in our finished goods,” said Chemesis CEO, Edgar Montero. The manufacturing expansion will maximize efficiencies, and will also increase production capacity for Chemesis’ brands, including California Sapand Jay & Silent Bob’s Private Stash, as well as third party brands.
“Chemesis believes this additional manufacturing will not only allow us to increase our capabilities to produce finished goods, but also allow us to further expand our presence in California,” added Montero. “The California market is a key part of Chemesis’ business plan and the Company will continue to take advantage of upcoming opportunities in this market. To date, our brands have garnered significant interest, and this additional manufacturing space gives us the ability to further meet consumer demand.”
On Behalf of The Board of Directors
CEO and Director
About Chemesis International Inc.
Chemesis International Inc. is a vertically integrated global leader in the cannabis industry, currently operating within California, Puerto Rico, and Colombia.
Chemesis is developing a strong foothold in key markets, from cultivation, to manufacturing, distribution and retail. Chemesis has facilities in both Puerto Rico and California, allowing for cost effective production and distribution of its products. In addition, Chemesis leverages exclusive brands and partnerships and uses the highest quality extraction methods to provide consumers with quality cannabis products.
Chemesis will add shareholder value by exploring opportunities in emerging markets while consistently delivering quality product to its consumers from seed to sale.
1 (604) 398-3378
Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future of the Company’s business, its product offerings and plans for sales and marketing, including finalizing an acquisition in Colombia. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation and does not intend to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release
News by QuoteMedia